- Home
- MBBC vs CLGN Comparison
MBBC vs CLGN Comparison
Compare MBBC & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBBC
- CLGN
- Stock Information
- Founded
- MBBC 1902
- CLGN 2004
- Country
- MBBC United States
- CLGN Israel
- Employees
- MBBC N/A
- CLGN N/A
- Industry
- MBBC Banks
- CLGN Industrial Specialties
- Sector
- MBBC Finance
- CLGN Health Care
- Exchange
- MBBC Nasdaq
- CLGN Nasdaq
- Market Cap
- MBBC 30.8M
- CLGN 33.8M
- IPO Year
- MBBC N/A
- CLGN N/A
- Fundamental
- Price
- MBBC $10.40
- CLGN $2.23
- Analyst Decision
- MBBC
- CLGN Strong Buy
- Analyst Count
- MBBC 0
- CLGN 2
- Target Price
- MBBC N/A
- CLGN $11.50
- AVG Volume (30 Days)
- MBBC 3.2K
- CLGN 250.5K
- Earning Date
- MBBC 11-22-2025
- CLGN 11-26-2025
- Dividend Yield
- MBBC N/A
- CLGN N/A
- EPS Growth
- MBBC N/A
- CLGN N/A
- EPS
- MBBC 0.02
- CLGN N/A
- Revenue
- MBBC $6,885,334.00
- CLGN $2,402,000.00
- Revenue This Year
- MBBC N/A
- CLGN $1,617.28
- Revenue Next Year
- MBBC N/A
- CLGN $83.54
- P/E Ratio
- MBBC $720.05
- CLGN N/A
- Revenue Growth
- MBBC 1.92
- CLGN 248.62
- 52 Week Low
- MBBC $6.42
- CLGN $1.31
- 52 Week High
- MBBC $12.00
- CLGN $4.99
- Technical
- Relative Strength Index (RSI)
- MBBC 55.54
- CLGN 40.00
- Support Level
- MBBC $10.32
- CLGN $2.21
- Resistance Level
- MBBC $10.48
- CLGN $3.18
- Average True Range (ATR)
- MBBC 0.04
- CLGN 0.22
- MACD
- MBBC -0.01
- CLGN -0.06
- Stochastic Oscillator
- MBBC 54.55
- CLGN 6.00
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.